QDEL - Quidel Corporation
Quidel Corporation Logo

QDEL - Quidel Corporation

https://www.quidelortho.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for infectious disease, cardiology, thyroid, general and women's health, eye health, gastrointestinal disease, and toxicology applications globally. The company is headquartered in San Diego, California.

52W High
$49.45
52W Low
$22.05
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.15
Valuation
Attractive
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
8.41
EV/EBITDA (<8 favorable)
21.74
EV/Revenue (<3 favorable)
1.67
P/S (TTM) (<3 favorable)
0.71
P/B (<3 favorable)
0.70
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
0.92%
Institutions (25–75% balanced)
117.81%
Shares Outstanding
67,900,000
Float
62,649,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
2,741,600,000
Gross Profit (TTM)
1,296,600,000
EPS (TTM)
-6.84
Profit Margin (>10% good)
-0.17%
Operating Margin (TTM) (higher better)
-0.01%
ROE (TTM) (>15% strong)
-0.16%
EPS YoY (Quarterly) (>10% good)
-0.77
Revenue YoY (Quarterly) (>8% good)
-0.04
Momentum
Bearish momentum
Value
0.6477
Previous
0.6709
Trend
Falling
Signal Cross
No cross
As of
Sep. 04, 2025